Use as directed and consult a healthcare provider when needed
Subcutaneous injection near wound sites delivers concentrated peptide directly to healing tissue while also providing systemic distribution that may support overall repair processes
As mentioned above, a number of compounds or drug formulations have been investigated with regard to inhibiting cysteine metabolism, either by targeting H 2 S-synthesising trans-sulphuration pathway enzymes (e.g
Khavinson (2014, August) Groundbreaking research shows that short peptides can regulate gene expression, repair DNA, and significantly slow aging processes at the cellular level
What Practitioners Report Practitioners using this stack in clinical settings typically describe it in three functional phases: (1) a 4-week GHK-Cu loading phase to build tissue-level copper-tripeptide availability before introducing sermorelin, (2) a concurrent 12-week phase combining nightly sermorelin with GHK-Cu on a 5-days-on/2-days-off schedule, and (3) a maintenance phase reassessing IGF-1 levels at 90 days to guide sermorelin dose titration
[Abstract] SSRN